Tiny study halted early after tracking bone chemicals in myeloma
NCT ID NCT04111809
Summary
This study aimed to understand how certain chemicals in the blood and urine, which indicate bone health, change over time in older patients with multiple myeloma. The patients were receiving a standard intravenous medication to strengthen their bones. The study was terminated early after enrolling only three participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Necker Hospital, Adult haematology department
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.